In The News



Preliminary drug tests show positive results
Colleen Cosgrove, Business Reporter • The Chronicle Herald
Date: Oct 25, 2012
Vaccine trial gets good results
Brett Bundale • The Chronicle Herald
Date: Oct 09, 2012
Winning Immunity
Janet Damianopoulos • Biotechnology Focus
Date: Aug 23, 2012
Immunovaccine loss attributed to R&D costs
Brett Bundale • The Chronicle Herald
Date: Aug 17, 2012
Halifax biotechnology firm working on next generation of pet vaccines
Brett Bundale, Business Reporter • The Chronicle Herald
Date: May 11, 2012
Passive vaccine could treat cocaine overdose
Suzanne Elvidge • FierceVaccines
Date: Apr 19, 2012
Halifax biotech firms get results in U.S.
John Demont • The Chronicle Herald
Date: Apr 05, 2012
Could a vaccine crack cocaine abuse?
By Suzanne Elvidge • FierceVaccines
Date: Mar 15, 2012
Nova Scotia's Immunovaccine partners with U.S. college in addiction research
By Brett Bundale • The Chronicle Herald
Date: Mar 14, 2012
Immunovaccine, Weill Cornell Medical College to Progress Anti-cocaine Vaccine
GEN- Genetic Engineering & Biotechnology News
Date: Mar 12, 2012
Biotech company raises $2.8 million for R&D
John Demont, Business Reporter • The Chronicle Herald
Date: Mar 08, 2012
Other News to Note
BioWorld Today
Date: Feb 16, 2012
Immunovaccine is developing NIH-funded biodefense vaccines
By Suzanne Elvidge • FierceVaccines
Date: Feb 16, 2012
Immunovaccine's delivery platform to be tested in fight against bioterrorism
Bill Power • The Chronicle Herald
Date: Feb 15, 2012
Biotech firm to issue shares
By John Demont • The Chronicle Herald
Date: Feb 10, 2012
Orphan Drugs, Growth and Controlling Risk Headline J. P. Morgan
Gail Dutton • Genetic Engineering & Biotechnology News
Date: Jan 16, 2012
Immunovaccine, Inc: Developing More Effective Cancer Vaccines
by Dr. Marc Mansour • Drug Development & Delivery
Date: Jan 12, 2012
Clinic Roundup
BioWorld
Date: Jan 05, 2012
Anti-cancer Drug Trials Start
Joann Alberstat • The Chronicle Herald
Date: Jan 04, 2012